Advanced Search
ZHANG Ruiqing, YANG Wenqian, YU Yubing, TU Jiasheng, SUN Yixin. Pharmacokinetics of nifedipine matrix sustained-release pellets in rats and the relationship with CYP3A4[J]. Journal of China Pharmaceutical University, 2018, 49(4): 427-432. DOI: 10.11665/j.issn.1000-5048.20180407
Citation: ZHANG Ruiqing, YANG Wenqian, YU Yubing, TU Jiasheng, SUN Yixin. Pharmacokinetics of nifedipine matrix sustained-release pellets in rats and the relationship with CYP3A4[J]. Journal of China Pharmaceutical University, 2018, 49(4): 427-432. DOI: 10.11665/j.issn.1000-5048.20180407

Pharmacokinetics of nifedipine matrix sustained-release pellets in rats and the relationship with CYP3A4

More Information
  • To conduct the characterization of its pharmacokinetics in rats of nifedipine sustained-release pellets and to study the relationship between the pellets and CYP3A4 activity. A gradient HPLC method was developed to simultaneously determine 6β-hydroxycortisol and hydrocortisone. CYP3A4 activity of rats was quantified by urinary ratio of 6β-hydroxycortisol/hydrocortisone after intravenous injection of hydrocortisone as a biomarker. HPLC method was also developed to quantify the drug concentration in plasma of rats, and the studies of pharmacokinetics were performed after oral administration of single dose of two formulations: Nifedipine matrix sustained-release pellets and nifedipine tablet(using as control). The results showed that the ratio of ten rats was 0. 271±0. 129. cmax of nifedipine sustained-release pellets decreases by nearly 70%, tmax significantly increased by 400% and t1/2 and MRT significantly increased by 230% compared to control. Nifedipine sustained-release pellets had a significant sustained-release property compared to the control and CYP3A4 activity affected its pharmacokinetics behavior.
  • [1]
    He Q,Yang J.Development of digital gastrointestinal model and its application in absorption prediction of nifedipine sustained-release tablets[J].J China Pharm Univ(中国药科大学学报),2012,43(1):85-91.
    [2]
    Foster TS,Hamann SR,Richards VR,et al.Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects[J].J Clin Pharmacol,1983,23(4):161-170.
    [3]
    Raemsch KD, Sommer J. Pharmacokinetics and metabolism of nifedipine[J] Hypertension,1983,5(4 Pt 2):18-24.
    [4]
    Horster FADB.Clinical investigations on the pharmacokinetics of radioactively marked 4-(2′nitrophenyl)-2,6-dimethyl-1,4-dihydropydine-3,5-dicarboxylic acid dimethrl ester[J].Arzneimittel-Forsch,1972,22:330-334.
    [5]
    Xie SS,Jing XY,Liu XD.Role of intestinal cytochrome P450s in drug metabolism[J].J China Pharm Univ(中国药科大学学报),2010,41(2):186-192.
    [6]
    De Wildt SN,Kearns GL,Leeder JS,et al.Cytochrome P450 3A:ontogeny and drug disposition[J].Clin Pharmacokinet,1999,37(6):485-505.
    [7]
    Kearns GL,Robinson PK,Wilson JT,et al.Cisapride disposition in neonates and infants:in vivo reflection of cytochrome P450 3A4 ontogeny[J].Clin Pharmacol Ther,2003,74(4):312-325.
    [8]
    Chiou WL,Jeong HY,Wu TC,et al.Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization[J].Clin Pharmacol Ther,2001,70(4):305-310.
    [9]
    Tateishi T, Watanabe M, Nakura H, et al. CYP3A activity in European American and Japanese men using midazolam as an in vivo probe[J].Clin Pharmacol Ther,2001,69(5):333-339.
    [10]
    Yamamoto N, Tamura T, Kamiya Y, et al. Correlation between docetaxel clearance and estimated cytochrome P450 activity by urinary metabolite of exogenous cortisol[J].J Clin Oncol,2000,18(11):2301.
    [11]
    Yu YB,Tu JS.Preparation and comparison of two types of nifedipine sustained-release pellets[J].Pharm Clin Res,2010,18(3):235-238.
    [12]
    Zhang SG,Chen ML,Tang YN.Determination of urinary hydrocortisone and 6β-hydroxycortisol by HPLC[J].Chin J Hosp Pharm(中国医院药学杂志),2004,24(012):733-735.
    [13]
    Suzuki H,Fujiwara S,Kondo S,et al.Determination of nifedipine in human plasma by high-performance liquid chromatography with electrochemical detection[J].J Chromatogr B Biomed Sci Appl,1985,341:341-347.
    [14]
    Yritia M,Parra P,Iglesias E,et al.Quantitation of nifedipine in human plasma by on-line solid-phase extraction and high-performance liquid chromatography[J].J Chromatogr A,2000,870(1/2):115-119.
    [15]
    Hang TJ,Zhang L.Relative bioavailability and pharmacokinetics of two oral nifedipine sustained-release capsules in Chinese volunteers after single dose administration[J].Chin J Med Chemistry(中国药学杂志),2000,35(10):681-683.
  • Related Articles

    [1]WANG Ziyuan, TAO Hui, XIAO Yingxue, YIN Zhiqi. Network pharmacology-based study of the mechanism of Ginkgo biloba extract (GBE) in the treatment of atherosclerosis by activating PPARγ[J]. Journal of China Pharmaceutical University, 2025, 56(2): 225-235. DOI: 10.11665/j.issn.1000-5048.2024032301
    [2]DONG Xiaoqiang, WEN Chang, XU Jindan, SHI Lexue, HU Yulong, LI Jieming, DONG Chunhong, DING Kan. Research progress on active mechanism and structure feature of polysaccharides from Zizyphus jujube in Rhamnaceae plants[J]. Journal of China Pharmaceutical University, 2024, 55(4): 443-453. DOI: 10.11665/j.issn.1000-5048.2024051301
    [3]LU Zhipeng, XU Qinglong, CHEN Panpan, QIN Yajuan, TANG Lijun, LI Tingyou. Research progress of radioprobes targeting fibroblast activating protein[J]. Journal of China Pharmaceutical University, 2022, 53(6): 651-662. DOI: 10.11665/j.issn.1000-5048.20220603
    [4]MA Rui, TIAN Jinhua, JIANG Jun, JIN Xin. Inhibitory activities of ginsenosides on the activation of NLRP3 inflammasome[J]. Journal of China Pharmaceutical University, 2016, 47(5): 614-618. DOI: 10.11665/j.issn.1000-5048.20160519
    [5]ZHU Kuiniu, WU Zhengfeng, JIANG Cuihua, CAO Lanjie, ZHANG Jian, YIN Zhiqi. Advances on hypoglycemic activity and mechanism of triterpenoids[J]. Journal of China Pharmaceutical University, 2015, 46(6): 764-770. DOI: 10.11665/j.issn.1000-5048.20150622
    [6]SHEN Kai, KOU Junping, YU Boyang. Research advances in the mechanisms of active components in Chinese materia medica against oxidative stress-induced neuronal apoptosis[J]. Journal of China Pharmaceutical University, 2015, 46(5): 532-540. DOI: 10.11665/j.issn.1000-5048.20150503
    [7]WU Keqin. Antitumor activity and mechanism of saikosaponin D combined with oxaliplatin on A549 cells-bearing nude mice[J]. Journal of China Pharmaceutical University, 2015, 46(3): 355-358. DOI: 10.11665/j.issn.1000-5048.20150316
    [8]ZHANG Qian, CHEN Cen, YANG Fengqing, XIA Zhining. Mechanism of agonist-induced platelet activation and research progress of anti-platelet drugs[J]. Journal of China Pharmaceutical University, 2014, 45(6): 632-648. DOI: 10.11665/j.issn.1000-5048.20140604
    [9]SONG Huayuan, ZHOU Danli, HAN Yuan, LIU Wentao. Baicalin attenuates morphine tolerance through suppressing spinal microglia activation in mice[J]. Journal of China Pharmaceutical University, 2014, 45(3): 346-351. DOI: 10.11665/j.issn.1000-5048.20140317
    [10]CHENG Yu-si, DAI De-zai, JI Hui, DAI Yin. Mechanism of endothelin receptor antagonist CPU0213 and calcium antagonist CPU86017 ameliorated rats′ heart failure induced by isoproterenol[J]. Journal of China Pharmaceutical University, 2011, 42(1): 58-63.
  • Cited by

    Periodical cited type(4)

    1. 谢金平,黄淼,朱梦雅,陈怡,邵蓉. 监管科学视角下增材制造(3D打印)药物研发上市关键问题及监管政策研究. 中国食品药品监管. 2025(02): 50-61 .
    2. 王美晴,段小群. 3D打印技术在药物制剂领域的研究进展. 广东化工. 2024(02): 67-68+62 .
    3. 张隽齐,杨柳榴,陈芳. 3D打印技术在膜剂制备中的研究进展. 中国医药工业杂志. 2024(03): 326-334 .
    4. 谭志柱,梁兆铭,邓永健. 3D打印技术在汽车轮胎模具领域的应用案例分析. 机电工程技术. 2024(12): 131-134 .

    Other cited types(4)

Catalog

    Article views (1280) PDF downloads (1560) Cited by(8)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return